Axsome Therapeutics, Price Chart
Axsome Therapeutics, Volume Chart
Axsome Therapeutics, Market Segments
After Hours
+2.02(+1.23%)
| Open | $164.05 |
|---|---|
| Close | $166.07 |
| Low | $164.05 |
| Low Change | 0.00 (0.00%) |
| High | $166.07 |
| High Change | +2.02 (+1.23%) |
| Range | $2.02 |
| Volume | 2.941K |
| Dollar Volume | $488.41K |
Regular Trading Hours
-0.62(-0.38%)
| Open | $164.77 |
|---|---|
| Close | $164.15 |
| Low | $163.18 |
| Low Change | -1.59 (-0.96%) |
| High | $167.72 |
| High Change | +2.95 (+1.79%) |
| Range | $4.54 |
| Volume | 501.814K |
| Dollar Volume | $82.37M |
Premarket
*No Trades in Segment
After Hours Yesterday
+0.00(+0.00%)
| Open | $166.38 |
|---|---|
| Close | $166.38 |
| Low | $166.38 |
| Low Change | 0.00 (0.00%) |
| High | $166.38 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 5.022K |
| Dollar Volume | $835.56K |
Regular Trading Hours Yesterday
+4.20(+2.59%)
| Open | $162.06 |
|---|---|
| Close | $166.26 |
| Low | $161.18 |
| Low Change | -0.88 (-0.54%) |
| High | $168.00 |
| High Change | +5.94 (+3.67%) |
| Range | $6.82 |
| Volume | 441.544K |
| Dollar Volume | $73.41M |
Premarket Yesterday
+0.89(+0.55%)
| Open | $163.00 |
|---|---|
| Close | $163.89 |
| Low | $163.00 |
| Low Change | 0.00 (0.00%) |
| High | $163.89 |
| High Change | +0.89 (+0.55%) |
| Range | $0.89 |
| Volume | 4.833K |
| Dollar Volume | $792.08K |
Axsome Therapeutics, Moving Averages
| 5 Day Moving Average (SMA5) | $165.52 |
|---|---|
| 10 Day Moving Average (SMA10) | $174.08 |
| 20 Day Moving Average (SMA20) | $179.03 |
| 50 Day Moving Average (SMA50) | $174.17 |
| 100 Day Moving Average (SMA100) | $156.21 |
| 200 Day Moving Average (SMA200) | $133.32 |
Axsome Therapeutics, Statistics
| Average Volume (30 Days) | 642.78K |
|---|---|
| P/E Ratio (Current) | -45.78 |
| EPS (Current) | -$3.58 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$93.89M |
| Cash Ratio | 0.85 |
| Current Ratio | 1.55 |
| Quick Ratio | 1.48 |
| Debt to Equity | 2.17 |
| Enterprise Value | $8.25B |
| EV to EBITDA | -51.62 |
| EV to Sales | 12.92 |
| Price to Book | 94.95 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 13.13 |
| Return on Assets | -0.27% |
| Return on Equity | -2.07% |
Axsome Therapeutics, Stock Splits
There have been no stock splits for Axsome Therapeutics, (AXSM).